Capital in Biological Technology

Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City

SAN CARLOS, Calif., July 31 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) is scheduled to present at the upcoming BMO Capital Markets 9th Annual Focus on Healthcare Conference at the Millennium Broadway Hotel in New York City on Wednesday, August 5, 2009 at 1:45 p.m. ...

Sunesis Receives Approval for Listing on The NASDAQ Capital Market

SOUTH SAN FRANCISCO, Calif., July 30 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced th...

PDL BioPharma to Present at BMO Capital Markets Healthcare Conference on August 5, 2009

INCLINE VILLAGE, Nev., July 29 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the BMO Capital Markets Healthcare Conference in New York City on Wednes...

KTA Capital Advises SpringTree Global Investors on an AU$25.5 Million Investment in Prima BioMed Ltd

SpringTree Special Opportunities Fund, LP ("SpringTree") announced today its AU$25,500,000 investment in Prima BioMed Ltd (ASX:PRR), an Australian Securities Exchange-listed oncology biotechnology company. KTA Capital acted as the exclusive financial advisor to SpringTree's general part...

Viral Genetics Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances

SAN MARINO, Calif., July 13 /PRNewswire-FirstCall/ -- Viral Genetics (Pink Sheets: VRAL), a biotechnology company that develops drug compounds for HIV/AIDS, autoimmune diseases, and cancer, has retired the majority of its $3.5 million of convertible debt. The company also retired other ...

AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS

VIENNA, Austria, June 23 /PRNewswire/ -- MIG Fonds and AFFiRiS AG are this year's winners of the 2009 Venture Capital & Private Equity Award competition, hosted by the industry magazine Boerse-Express and Junge Industrie. The award recognised the long-standing association between the Germa...

Top CEOs Declare America's Manufacturing Sector Requires Pro-Industry Policies, Capital Management and Innovation to Maintain Economic Leadership

DETROIT, June 15 /PRNewswire/ -- Business, nonprofit and advocacy leaders today have called for a recovery of the manufacturing sector that includes enacting pro-industry policies and regulation that drive research and development, managing capital and investment, and creating new demand th...

Venture Capital Veteran John Brooks Joins Life Science Investment Bank Johnston Blakely & Company

BOSTON, May 4 /PRNewswire/ -- Johnston Blakely & Company, LLC, a Boston-based life science investment bank, is pleased to announce that John L. Brooks, III has joined the firm as senior advisor. In this role, Mr. Brooks will participate with the firm on internal and client-related activities ...

Cell Therapeutics Satisfies NASDAQ Listing Requirements to Continue to Trade on NASDAQ Capital Market

SEATTLE, April 3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that on April 2, 2009, CTI received notice from The NASDAQ Stock Market ("NASDAQ") indicating that the company has evidenced full compliance with all applicable requirements for continue...

Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India

Joint Venture to be funded by Cadila Pharmaceuticals and Revenues from Sales of Biogenerics; Deal Includes $11 Million Capital Investment in Novavax ROCKVILLE, Md., March 31 /PRNewswire-FirstCall/ -- Novavax Inc. (Nasdaq: NVAX ) announced today it has formed a joint venture with Cadila P...

Merck Serono Launches Strategic Venture Capital Fund

- New Venture Capital Fund Will Invest in Biotech Start-up Companies Focused on Merck Serono's Core Therapeutic Areas GENEVA, March 23 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the formation of 'Merck Serono Ventures', a strategic, cor...

Kendle to Present at Upcoming Barclays Capital and Raymond James Conferences

CINCINNATI, March 9 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL ), a leading, global full-service clinical research organization, today announced Chief Operating Officer Christopher Bergen will participate in the Barclays Capital Global Healthcare Conference on March 10 as well as the Raymond...

Schering-Plough to Webcast Presentation at Barclays Capital Global Healthcare Conference

KENILWORTH, N.J., March 5 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) will provide a live audio webcast of a presentation by David Nicholson, Ph.D., senior vice president, Global Project Management & Drug Safety, Schering-Plough Research Institute, at the Barclays Capi...

Volcano Corporation Presentation at Roth Capital Partners Conference to Be Webcast

SAN DIEGO, Feb. 12 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC ), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the Roth Capital Partners ...

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference

SAN DIEGO, Feb. 10 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's Presi...

China-Biotics, Inc. to Present at Roth Capital Partners 21st Annual OC Growth Stock Conference

SHANGHAI, China, Feb. 10 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT ) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced members of the Compa...

deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market

REYKJAVIK, Iceland, February 3 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN ) announced that on February 2, 2009, it received a letter from the Nasdaq Listing Qualifications Panel (the "Panel") stating that the Panel will transfer the listing of deCODE's common stock from the Nasda...

Aisling Capital Announces Close of US$650M Life Sciences Fund

NEW YORK, Jan. 7 /PRNewswire/ -- Aisling Capital announced today that it raised US$650 million in committed capital for its newest life sciences fund, Aisling Capital III, LP. Aisling Capital will invest its third fund primarily in companies developing pharmaceutical, biopharmaceutical and medical...

Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market

SEATTLE, Jan. 7 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that it has received notification that the NASDAQ Listing Qualifications Panel has granted CTI's request to transfer the listing of its common stock from The NASDAQ Global Market to T...

Rigel to Participate at the RBC Capital Markets Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Dec. 8 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that James M. Gower, Rigel's chairman and chief executive officer, will participate in a panel discussion at the 2008 RBC Capital Marketing Healthcare Conference. The panel, ...

Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2008 Healthcare Conference

REHOVOT, Israel and JERSEY CITY, New Jersey, December 5 /PRNewswire-FirstCall/ -- Rosetta Genomics Ltd (Nasdaq: ROSG ), a leader in the development of microRNA-based diagnostics and therapeutics, announced today that it will present at RBC Capital Markets 2008 Healthcare Conference on Thursda...

Micromet to Present at the RBC Capital Markets Healthcare Conference

BETHESDA, Md., Dec. 5 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that its President and Chief Executive Officer, Dr. Christian ...

Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference

SAN FRANCISCO, Dec. 4 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN ) today announced that David Hung, M.D., president and chief executive officer, will be a featured speaker on two panels at the RBC Capital Markets 2008 Healthcare Conference on Thursday, December 11, in New York: ...

AEterna Zentaris to Present at Upcoming RBC Capital Markets Healthcare Conference

QUEBEC CITY, Dec. 4 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS , TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its President and CEO, Juergen Engel, Ph.D., will take part in a panel discussion titled, "Replacing Th...

OncoGenex To Present At The RBC Capital Markets 2008 Healthcare Conference

BOTHELL, WA, and VANCOUVER, Dec. 4 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc (NASDAQ: OGXI ) will participate on the 'Waging a Battle Against Cancer' panel at the RBC Capital Markets 2008 Healthcare Conference on Thursday, December 11 at 8:00 am ET at the Westin Times Square Hotel ...

Abaxis, Inc. to Present at the RBC Capital Markets 2008 Healthcare Conference

UNION CITY, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, CEO and President, will participate in a panel discussion titled "Getting To The Point Of Care" o...

Medarex to Present at the RBC Capital Markets Healthcare Conference

PRINCETON, N.J., Dec. 3 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) announced today that it is scheduled to present at the RBC Capital Markets Healthcare Conference at 3:30 p.m. Eastern Time on Wednesday, December 10, 2008. The event will be webcast live and will be available in the ...

Celator(R) Pharmaceuticals to Present at Piper Jaffray Health Care Conference and Mid-Atlantic Capital Conference

PRINCETON, N.J., Nov. 25 /PRNewswire/ -- Celator Pharmaceuticals today announced that Scott Jackson, chief executive officer, is scheduled to present at the 20th Annual Piper Jaffray Health Care Conference in New York and the 2008 Mid-Atlantic Capital Conference in Philadelphia. Mr. Jackson will ...

Jazz Pharmaceuticals Cancels Presentation Planned for November 19, 2008 at Lazard Capital Markets 5th Annual Healthcare Conference

PALO ALTO, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced that it has cancelled its corporate presentation planned for today at the Lazard Capital Markets 5th Annual Healthcare Conference due to the proximity of the release of preliminary top-line ...

Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th

EAST BRUNSWICK, N.J., Nov. 13 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced that Christopher Clement, President and Chief Executive Officer of Savient Pharmaceuticals will present a corporate update at the upcoming Lazard Capital Markets 5th Annual He...

Gen-Probe to Webcast Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference

SAN DIEGO, Nov. 13 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that the Company will present at the Lazard Capital Markets 5th Annual Healthcare Conference on Tuesday, November 18, 2008 at approximately 3:10 p.m. Eastern Time. The presentation is scheduled...

Starfish Ventures Closes Australia's Largest Venture Capital Fund With $185 Million Tech Fund

MELBOURNE, Australia, Nov. 12 /PRNewswire/ -- Melbourne-based Starfish Ventures announced today the successful closure of its Starfish Technology Fund II at $185 million, the largest venture capital fundraising in Australia. The fund will invest in ICT, Life Sciences and Cleantech companies. ...

Beckman Coulter to Present at the Lazard Capital Markets 5th Annual Healthcare Conference

ORANGE COUNTY, Calif., Nov. 12 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that Charlie Slacik, Beckman Coulter's senior vice preside...

Novavax CEO to Present at Lazard Capital Markets 5th Annual Healthcare Conference

ROCKVILLE, Md., Nov. 12 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the Lazard Capital Markets 5th Annual Healthcare Conference at 3:00 pm. (EST) ...

Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference

CRANBURY, N.J., Nov. 11 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD ), today announced President and CEO, John F. Crowley, will make a presentation at the 5th Annual Lazard Capital Markets Healthcare Conference in New York on Tuesday, November 18, 2008, at 5:10 p.m. EST. A w...

Spherix Transfers Stock Listing to Nasdaq Capital Market

BETHESDA, Md., Nov. 10 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX ) reported that the Nasdaq Stock Market has approved its application to transfer the listing of its common stock from the Nasdaq Global Market to the Nasdaq Capital Market. The common stock is expected to comm...

Yongye Biotechnology to Present at Roth Capital 'China Comes to Vegas' Conference

BEIJING, Nov. 10 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB; "Yongye" or the "Company"), a leading developer, producer and distributor of nutrients for plants and animals, located in the People's Republic of China, today announced that t...

South Africa's Minister of Minerals and Energy Welcomes Denham Capital Investment in BioTherm Energy to Develop Power Generation Business

Partnership will help alleviate South African power crisis JOHANNESBURG, South Africa and BOSTON Nov. 9 /PRNewswire/ -- Denham Capital, a leading energy-focused global private equity firm, announced today that it will invest equity of up to R1,5 billion (US $150 million, 95 million pounds St...

Golub Capital Provides Debt Financing to Support the Acquisition of DNA Diagnostics Center, Inc. by MTS Health Investors, LLC

NEW YORK, Oct. 21 /PRNewswire/ -- Golub Capital today announced that it has provided a GOLD facility for the acquisition of DNA Diagnostics Center, Inc. (DDC) by MTS Health Investors, LLC (MTS). GOLD financings are proprietary Golub Capital One-Loan Debt facilities. Terms of the transaction we...

Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth

CLEVELAND, Ohio and TEL AVIV, Israel, October 15 /PRNewswire/ -- Simbionix USA Corporation is pleased to announce the completion of a Series C round of growth capital financing led by River Cities Capital Funds, along with incumbent investor Early Stage Partners and other existing shareholders...